Lion Street Advisors LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 11.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,393 shares of the exchange traded fund’s stock after buying an additional 450 shares during the quarter. Lion Street Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $396,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Avior Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the last quarter. Tidemark LLC increased its position in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $40,000. ORG Wealth Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $44,000. Finally, Howe & Rusling Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $49,000.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA:XBI opened at $94.70 on Thursday. The firm has a market capitalization of $7.22 billion, a P/E ratio of 11.47 and a beta of 1.11. The business’s 50-day moving average is $92.88 and its 200 day moving average is $96.57. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Must-Have ETFs Set to Dominate This Quarter
- How to trade using analyst ratings
- Seeking Stability? These 3 Stocks Offer Strong Potential
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.